Training Level: Provider
Thursday, March 18th, 2021 from 2:00 – 3:00 PM Eastern
|VEKLURY® (remdesivir) is the first and only antiviral approved for the treatment of patients requiring hospitalization for COVID-19. Join us to find out more information on when and why this drug should be used for COVID-19 treatment.|
Grayce Kim, Pharm.D.
Principal Medical Scientist
Gilead Sciences, Inc.